Register for the 2022 Policy Outlook Webinar Today; Ask Congress to Support Cures 2.0; AMCP Releases State Model Legislation; CMS Actions on Alzheimer’s Drugs and 2023 Part D Rule; Request for Medicare Payment Advisory Commission(MedPAC) Nominations.
From thought-provoking keynote sessions to networking opportunities, AMCP CEO, Susan Cantrell, MHL, RPh, CAE, highlights what AMCP 2022 attendees can look forward to at the annual meeting.
February 2022 News & Views: Stay Ahead of the Curve at AMCP 2022; AMCP to Hold First Health Disparities Summit June 9; Consequences of Putting a Band-Aid on a Virus; Tune Into the 2022 Policy Outlook Webinar On-Demand; AMCP Launches New Affiliate, AMCP Carolinas.
Sponsored webinar that discussed the updated Continuous Glucose Monitoring technology Standards of Care and learn about the current evidence that influenced recent changes.
On Feb. 14, AMCP joined a pharmacy stakeholder letter supporting Dr. Robert Califf's nomination for FDA Commissioner, a post he previously held in 2016.
On Feb. 9, AMCP submitted comments to CMS supporting the agency's proposal to cover anti-amyloid monoclonal antibodies through the Coverage with Evidence Development pathway.